**Core Concept**
Ziconotide is a non-opioid, synthetic peptide that is used as an analgesic in the treatment of severe pain. It is a calcium channel blocker that specifically targets N-type calcium channels in the nervous system.

**Why the Correct Answer is Right**
Ziconotide binds to the alpha-2-delta subunit of N-type calcium channels, which are involved in the release of neurotransmitters such as glutamate and substance P. By blocking these channels, ziconotide reduces the influx of calcium ions into the presynaptic neuron, leading to a decrease in neurotransmitter release and consequently, a reduction in pain transmission. This mechanism is unique to ziconotide and is distinct from other calcium channel blockers, such as verapamil, which primarily target L-type calcium channels.

**Why Each Wrong Option is Incorrect**
* **Option A:** Ziconotide does not act by blocking alpha-1 adrenergic receptors, which are involved in vasoconstriction and other sympathetic responses. Blocking these receptors would not account for its analgesic effects.
* **Option B:** Ziconotide does not act by inhibiting the enzyme cyclooxygenase (COX), which is involved in the synthesis of prostaglandins and is targeted by nonsteroidal anti-inflammatory drugs (NSAIDs). Inhibiting COX would not account for its unique mechanism of action.
* **Option C:** Ziconotide does not act by blocking potassium channels, which are involved in regulating the resting membrane potential of neurons. Blocking potassium channels would not account for its analgesic effects.

**Clinical Pearl / High-Yield Fact**
Ziconotide's unique mechanism of action makes it a useful adjunct in the treatment of severe pain, particularly in patients who have developed tolerance to opioids. Its use is often reserved for patients who have failed other treatments or have severe side effects from other analgesics.

**Correct Answer:** C. N-type calcium channels.